EUVIMEDEUVIMED entdecken
Systematische Übersicht

Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy

Amy G Cantor, Rebecca Holmes, Christina Bougatsos, Chandler Atchison, Thomas DeLoughery, Roger Chou

JAMA · 17.09.2024 · 332 (11) · 914

DOI: 10.1001/jama.2024.13546 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA, erschienen am 17.09.2024. Verfasst von Amy G Cantor und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University…. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Dietary Supplements, Iron, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance In 2015 the US Preventive Services Task Force (USPSTF) found insufficient evidence to assess the balance of benefits and harms of routine screening and supplementation for iron deficiency anemia during pregnancy.

Objective

To update the 2015 review on screening for iron deficiency anemia, in addition to iron deficiency during pregnancy, to inform the USPSTF. Data Sources Ovid MEDLINE and Cochrane databases through May 24, 2023; surveillance through May 24, 2024. Study Selection Randomized clinical trials of iron supplementation, screening effectiveness, treatment, and harms; observational studies of screening. Data Extraction and Synthesis Dual review of abstracts, full-text articles, study quality, and data abstraction. Data were pooled using a random-effects model. Main Outcomes and Measures Maternal and infant clinical outcomes, hematologic indices, and harms.

Results

Seventeen trials (N = 24 023) on maternal iron supplementation were included. Iron supplementation was associated with decreased risk of maternal iron deficiency anemia at term (4 trials, n = 2230; 8.6% vs 19.8%; relative risk, 0.40 [95% CI, 0.26-0.61]; I 2 = 20.5%) and maternal iron deficiency at term (6 trials, n = 2361; 46% vs 70%; relative risk, 0.47 [95% CI, 0.33-0.67]; I 2 = 81.9%) compared with placebo or no iron supplement. There were no statistically significant differences in maternal quality of life, rates of gestational diabetes, maternal hemorrhage, hypertensive disorders of pregnancy, cesarean delivery, preterm birth, infant low birth weight, or infants small for gestational age for maternal iron supplementation compared with placebo or no supplementation. Harms of iron supplementation included transient gastrointestinal adverse effects. No studies evaluated the benefits or harms of screening for iron deficiency or iron deficiency anemia during pregnancy. Data on the association between iron status and health outcomes, such as hypertensive disorders of pregnancy and preterm birth, were very limited. Conclusions and Relevance Routine prenatal iron supplementation reduces the incidence of iron deficiency and iron deficiency anemia during pregnancy, but evidence on health outcomes is limited or indicates no benefit. No studies addressed screening for iron deficiency or iron deficiency anemia during pregnancy. Research is needed to understand the association between changes in maternal iron status measures and health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyDietary SupplementsIronPregnancy Complications, HematologicFemaleHumansInfant, NewbornPregnancyIron DeficienciesMass Screening

Substanzen

Iron

Autor:innen und Institutionen

  • The Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland.
  • Department of Family Medicine, Oregon Health & Science University, Portland.
  • Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland.
  • Department of Hematology/Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland.
  • Department of General Internal Medicine, Oregon Health & Science University, Portland.

Zitieren

APA

Cantor, A. G., Holmes, R., Bougatsos, C., Atchison, C., DeLoughery, T., & Chou, R. (2024). Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy. JAMA, 332(11), 914. https://doi.org/10.1001/jama.2024.13546

Vancouver

Cantor AG, Holmes R, Bougatsos C, Atchison C, DeLoughery T, Chou R. Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy. JAMA. 2024;332(11):914. doi:10.1001/jama.2024.13546

BibTeX
@article{Cantor2024,
  author = {Cantor, Amy G and Holmes, Rebecca and Bougatsos, Christina and Atchison, Chandler and DeLoughery, Thomas and Chou, Roger},
  title = {Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {11},
  pages = {914},
  doi = {10.1001/jama.2024.13546}
}
Kostenlos starten →